Stimulation of ACTH and GH release by angiotensin II in normal men is mediated by the AT1 receptor subtype

Regulatory Peptides

Volumn 74, Issue 1, 1998, Pages 27-30

  Coiro, V ^a   Volpi, R ^a   Capretti, L ^b   Caffarri, G ^c   Colla, R ^c   Giuliani, N ^a   Chiodera, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Hospital of Codogno   (Italy)

^c Hospital of Guastalla   (Italy)

Author keywords

ACTH; Angiotensin II; GH; Losartan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CORTICOTROPIN; GROWTH HORMONE; LOSARTAN; NEOLOTAN; PLACEBO; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOLUNTEER;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMAN GROWTH HORMONE; HUMANS; LOSARTAN; MALE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; REFERENCE VALUES;

EID: 0031803374     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00008-1     Document Type: Article

References (25)

1. Phillips M.I. Function of angiotensin in the central nervous system. Ann Rev Physiol. 49:1987;413-435.
2. Ganong W.F. Blood, pituitary, and brain renin-angiotensin systems and regulation of secretion of anterior pituitary gland. Front. Neuroendocrinol. 14:1993;233-249.
3. Saavedra J.M. Brain and pituitary angiotensin. Endocr Rev. 13:1992;329-380.
4. Rayyis S.S., Horton R. Effect of angiotensin II an adrenal and pituitary function in man. J Clin Endocrinol Metab. 32:1971;539-546.
5. degli Uberti E.C., Transforini G., Margutti A., Rossi R., Ambrosio M.R., Pansini R. Stimulation of growth hormone and corticotropin release by angiotensin II in man. Metabolism. 39:1990;1062-1067.
6. Volpi R., Chiodera P., Capretti L., Caiazza A., Caffarri C., Magotti M.G., Boni S., Coiro V. Influence of nitric oxide on hypoglycemia- or angiotensin II-stimulated ACTH and GH secretion in normal men. Neuropeptides. 30:1996;528-532.
7. Saavedra J.M., Israel A., Plunkett L.M., Kurihara M., Shigematsu K., Correa F.M.A. Quantitative distribution of angiotensin II binding sites in rat brain by autoradiography. Peptides. 7:1986;679-687.
8. Leung K.H., Smith R.D., Timmermans B.M.W.M., Chiu A.T. Regional distribution of the two subtypes of angiotensin II receptor in rat brain using selective nonpeptide antagonists. Neurosci Lett. 123:1991;95-98.
9. Tsutsumi K., Saavedra J.M. Angiotensin II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function. Endocrinology. 129:1991;3001-3008.
10. Tsutsumi K., Saavedra J.M. Characterisation and development of angiotensin II receptors subtypes (AT1 and AT2) in rat brain. Am J Physiol. 261:1991;R209-R216.
11. Wright J.W., Harding J.W. Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept. 59:1995;269-295.
12. Barbella Y., Cieco M., Israel A. Effect of losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of centrally administered renin. PSEBM. 202:1993;401-406.
13. Nelson EB, Harm SC, Goldberg M, Shahinfar S, Goldberg A, Sweet CS. Clinical profile of the first angiotensin II (AT-1 specific) receptor antagonists. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, diagnosis and management. second ed. New York: Raven Press, 1995:3079-3098.
14. Lorenzen L.C., Ganong W.F. Effects of drugs related to L-ethyltryptamine stress-induced ACTH secretion in the dog. Endocrinology. 80:1967;888-892.
15. Gann D.S., Ward D.G., Carlson D.E. A homeostatic reflex. Rec Prog Hormone Res. 34:1978;357-400.
16. Ramsay D.J. Effects of circulating angiotensin II on the brain. Frontiers Neuroendocrinol. 7:1982;263-285.
17. Padfield P.L., Morton J.J. Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man. J Endocrinol. 74:1977;251-259.
18. Fagard R., Cattaert A., Lijnen P., Staessen J., Vanhees L., Moerman E., Amery A. Responses of the systemic circulation and the renin-angiotensin-aldosterone system to ketanserin at rest and exercise in normal man. Clin Sci. 66:1984;17-25.
19. Catt K.J., Cain M.D., Coghlan J.P., Zimmet P.Z., Cran E., Best J.B. Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension. Circ Res suppl II. 16 17:1970;177-193.
20. Moreau C., Rasolojanahary R., Zamora A.J., Enjalbert A., Kordon C., Llorens-Cortes C. Expression of angiotensin II receptor subtypes AT1A and AT1B in enriched fractions of dispersed rat pituitary cells. Neuroendocrinology. 66:1997;416-425.
21. Moreau C., Rasolojanahary R., Dudinot V., Kordon C., Enjalbert A. Angiotensin II effects on second messenger involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary. Mol Cell Neurosci. 5:1994;597-603.
22. Aguilera G., Hyde C.L., Catt K.J. Angiotensin II receptors and prolactin release in pituitary lactotrophs. Endocrinology. 111:1982;1045-1050.
23. Steele M.K., Negro-Vilar A., McCann S.M. Effect of angiotensin II on in vivo and in vitro releases of anterior pituitary hormones in the female rat. Endocrinology. 109:1981;893-899.
24. Steele M.K., McCann S.M., Negro-Vilar A. Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormones release. Endocrinology. 111:1982;722-729.
25. Robberecht W., Denef C. Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro. Endocrinology. 122:1988;1496-1504.